Streetbeat News

Products Services

TNXP

Tonix Pharmaceuticals has secured a $34 million contract from the U.S. Department of Defense to advance its TNX-4200 antiviral program. The company is collaborating with X-Chem to use AI and ML in developing oral antivirals. This partnership aims to optimize drug candidates' properties and accelerate development.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 11:12 am

PEP

QQQ

SPY

US stocks are set to rebound as bond yields dip and oil prices slide. Fed Governor Adriana Kugler's dovish comments on potential rate cuts and a focus on employment are boosting sentiment. However, PepsiCo's earnings miss and reduced growth outlook weigh on the market. ETFs like SPY and QQQ are seeing premarket gains.

Portfolio Pulse from Shanthi Rexaline

October 08, 2024 | 11:12 am

IAS

Integral Ad Science (IAS) is expanding its media quality coverage on TikTok to over 75 new markets. This expansion includes new placements such as Profile, Search, Following Feeds, and TikTok Lite. Additionally, IAS is testing a video exclusion list for advertisers to enhance ad targeting.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 11:12 am

OPT

Opthea has appointed Parisa Zamiri as Chief Medical Officer and Tom Reilly as Chief Financial Officer. The company is preparing for the Phase 3 data readouts of its Sozinibercept trials, COAST and ShORe, expected in 2025.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 11:12 am

EVGN

Watershed AC and Evogene Ltd. have received a grant to advance CRISPR technology for crustaceans, aiming to improve traits like growth rate and disease resistance. This collaboration targets sustainable aquaculture, focusing on giant freshwater prawn, white leg shrimp, and red swamp crayfish.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 11:11 am

BPTH

Bio-Path Holdings has launched a new therapeutic program to develop BP1001-A for treating obesity and related metabolic diseases. This marks the first use of their DNAbilize technology for a non-cancer application.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 11:08 am

TRAK

ReposiTrak has expanded its traceability network to include 4,000 suppliers, aiding retailers and wholesalers in preparing for FSMA 204 compliance. This expansion indicates that many suppliers are already traceability-ready.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 11:07 am

AVTX

Avalo Therapeutics has initiated the Phase 2 LOTUS trial for AVTX-009, targeting Hidradenitis Suppurativa. The trial will involve approximately 180 adults, with topline data expected in 2026.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 11:07 am

RCAT

Red Cat Holdings has secured $1.6 million in contracts for its Edge 130 Blue drones, which are military-grade tricopters approved for use by the U.S. Customs & Border Protection. The contract was facilitated by Darley and coordinated by the U.S. Defense Logistics Agency.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 11:05 am

TEVA

Teva Pharmaceutical Industries Ltd. announced that the FDA has accepted and the European Medicines Agency has validated applications for TVB-009P, a biosimilar candidate to Prolia. Decisions from both agencies are expected in the second half of 2025.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 11:01 am